McGill University Health Centre
McGill University Health Centre
Montreal, Quebec, Canada10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia | Community-Acquired Infections, Community-Acquired Pneumonia, Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2026-09-30 | NCT05848713 | |
| Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS) | Abnormalities, Multiple, Angelman syndrome, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Imprinting Disorders, central nervous system disorder, chromosomal disorder, hereditary disease, movement disorder, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-06 | NCT06617429 | |
| A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, respiratory system disorder, respiratory tract neoplasm, uterine disorder | Active, not recruiting | Phase 2 | 2026-07-22 | NCT06003231 | |
| Secondary Prevention of Clostridioides Difficile Using Vancomycin | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Phase 2 / Phase 3 | 2026-06-24 | NCT06979609 | |
| Online Prehabilitation for Patients Awaiting Liver Transplantation | Atrophy, Digestive System Diseases, Fibrosis, Frailty, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, cirrhosis of liver, liver disorder, muscular atrophy, nervous system disorder, nutritional deficiency disease, nutritional disorder | Recruiting | Not applicable | 2026-04-08 | NCT05899231 | |
| A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 3 | 2026-02-27 | NCT06346067 | |
| A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 4 | 2026-02-05 | NCT05495906 | |
| Single Patient Investigational Treatment for Cree Leukoencephalopathy | Leukoencephalopathies, brain disorder, central nervous system disorder, leukoencephalopathy with vanishing white matter 5, nervous system disorder | Active, not recruiting | Not applicable | 2026-01-16 | NCT07300397 | |
| Research Study for Single-Patient Treatment of Cree Leukoencephalopathy/Vanishing White Matter Disease | Leukoencephalopathies, brain disorder, central nervous system disorder, leukoencephalopathy with vanishing white matter 5, nervous system disorder | Active, not recruiting | Early phase 1 | 2025-12-30 | NCT07272525 | |
| Whole Heart Radiotherapy for End-stage Heart Failure | cardiovascular disorder, heart disorder, heart failure | Enrolling by invitation | Phase 1 | 2025-05-14 | NCT06299176 |